Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0000899243-23-016130

Options or other derivatives

  • Director acquired 79,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Adams Jerome M. Director 2023-06-16 Grant or award · Restricted Stock Units +33,150 33,150 D
Adams Jerome M. Director 2023-06-16 Grant or award · Stock Option (Right to Buy) +46,750 46,750 D
Loading xslF345X04/doc4.xml…